Immunoconjugates and immunotoxins for therapy of carcinomas

Adv Pharmacol. 1995:33:349-88. doi: 10.1016/s1054-3589(08)60674-2.

Authors

I Hellström¹, K E Hellström, C B Siegall, P A Trail

Affiliation

¹ Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington, USA.

PMID: 7495675
DOI: 10.1016/s1054-3589(08)60674-2

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Animals
Antibodies / therapeutic use*
Carcinoma / therapy*
Immunoconjugates / therapeutic use*
Immunotherapy
Immunotoxins
Methotrexate / therapeutic use

Substances

Antibodies
Immunoconjugates
Immunotoxins
Methotrexate